These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 6801143)

  • 41. Serological and biochemical analysis of Ia molecules in the I-A mutant B6.C-H-2.
    Lafuse WP; McCormick JF; Melvold RW; David CS
    Transplantation; 1981 Jun; 31(6):434-8. PubMed ID: 6167031
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Hybrid Ia antigens: genetic, serologic, and biochemical analyses.
    Lafuse WP; Yokota S; David CS
    J Supramol Struct; 1980; 14(1):97-106. PubMed ID: 6163928
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hybrid (combinatorial) Ia specificities: gene complementations to generate Ia.22.
    Lafuse WP; McCormick JF; Corser PS; David CS
    Immunogenetics; 1981; 13(1-2):115-25. PubMed ID: 6164634
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Class I MHC genes and CD8+ T cells determine cyst number in Toxoplasma gondii infection.
    Brown CR; McLeod R
    J Immunol; 1990 Nov; 145(10):3438-41. PubMed ID: 2121825
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cell-cell interaction in graft rejection responses: induction of anti-allo-class I H-2 tolerance is prevented by immune responses against allo-class II H-2 antigens coexpressed on tolerogen.
    Hori S; Kitagawa S; Iwata H; Ochiai T; Isono K; Hamaoka T; Fujiwara H
    J Exp Med; 1992 Jan; 175(1):99-109. PubMed ID: 1730930
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of amino acid substitutions within the region 62-76 of I-A beta b on binding with and antigen presentation of Torpedo acetylcholine receptor alpha-chain peptide 146-162.
    Oshima M; Atassi MZ
    J Immunol; 1995 May; 154(10):5245-54. PubMed ID: 7537303
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Genetic control of experimental autoimmune myasthenia gravis in mice. III. Ia molecules mediate cellular immune responsiveness to acetylcholine receptors.
    Christadoss P; Lennon VA; Krco CJ; David CS
    J Immunol; 1982 Mar; 128(3):1141-4. PubMed ID: 6799570
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Factors that determine the severity of experimental myasthenia gravis.
    Drachman DB; McIntosh KR; Yang B
    Ann N Y Acad Sci; 1998 May; 841():262-82. PubMed ID: 9668247
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Genetic control of the immune response to collagen. I. Quantitative determination of response levels by multiple I-region genes.
    Hedrick SM; Watson JD
    J Immunogenet; 1980 Jun; 7(3):271-83. PubMed ID: 6774029
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Genetic control of the antibody response to sperm whale myoglobin in mice.
    Berzofsky JA
    Adv Exp Med Biol; 1978; 98():225-39. PubMed ID: 102124
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Two-gene control of the expression of a murine Ia antigen.
    Jones PP; Murphy DB; McDevitt HO
    J Exp Med; 1978 Oct; 148(4):925-39. PubMed ID: 100572
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Structural polymorphism of I-E subregion antigens determined by a gene in the H-2K to I-B genetic interval.
    Silver J; Russell WA
    Nature; 1979 May; 279(5712):437-9. PubMed ID: 16068185
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Antigen-specific T cell clones restricted to unique F1 major histocompatibility complex determinants. Inhibition of proliferation with monoclonal anti-Ia antibody.
    Sredni B; Matis LA; Lerner EA; Paul WE; Schwartz RH
    J Exp Med; 1981 Mar; 153(3):677-93. PubMed ID: 6166704
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cytotoxic T lymphocytes generated across and I-Ab mutant difference are directed against a molecule bearing Ia antigens.
    de Waal LP; Melief CJ; Melvold RW
    Eur J Immunol; 1981 Mar; 11(3):258-65. PubMed ID: 6165590
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Genetic control of T-cell proliferative responses to poly(glu40ala60) and poly(glu51lys34tyr15): subregion-specific inhibition of the responses with monoclonal Ia antibodies.
    Baxevanis CN; Wernet D; Nagy ZA; Maurer PH; Klein J
    Immunogenetics; 1980; 11(6):617-28. PubMed ID: 6086092
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cytotoxic T lymphocyte nonresponsiveness to the male antigen H-Y in the H-2Db mutants bm13 and bm14. Complementation of the response in F1 crosses with the I-Ab mutant bm12 nonresponder and failure of B6 or Db mutant mice tolerant of each other to respond to allogeneic male cells.
    De Waal LP; Melvold RW; Melief CJ
    J Exp Med; 1983 Nov; 158(5):1537-46. PubMed ID: 6415206
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Mutation in the IA subregion of the murine H-2 complex.
    McKenzie IF; Sandrin MS; Morgan GM; Henning MM; Melvold RW
    Immunogenetics; 1980 Jul; 11(1):103-6. PubMed ID: 6777296
    [No Abstract]   [Full Text] [Related]  

  • 58. Antigen and MHC restriction specificity of two types of cloned male-specific T cell lines.
    Tomonari K
    J Immunol; 1983 Oct; 131(4):1641-5. PubMed ID: 6194209
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Assessment of antigen-specific restriction sites on Ia molecules as defined by the bm12 mutation.
    Kanamori S; Walsh WD; Hansen TH; Tse HY
    J Immunol; 1984 Dec; 133(6):2811-4. PubMed ID: 6208261
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Evidence for more than one Ia antigenic specificity on molecules determined by the I-A subregion of the mouse major histocompatibility complex.
    Cullen SE; David CS; Cone JL; Sachs DH
    J Immunol; 1976 Feb; 116(2):549-53. PubMed ID: 55444
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.